Crossmark

Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis

Crossref DOI link: https://doi.org/10.1007/s11255-022-03198-1

Published Online: 2022-04-01

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wada, Naoki https://orcid.org/0000-0002-9587-6798
Abe, Noriyuki

Miyauchi, Kotona

Ishikawa, Mayumi

Makino, Shogo

Kakizaki, Hidehiro
License Information

Text and Data Mining valid from 2022-04-01

Version of Record valid from 2022-04-01
More Information

Article History

Received: 16 February 2022

Accepted: 29 March 2022

First Online: 1 April 2022

Declarations

:

: Nothing to declare.

: Approval of the research protocol by an Institutional Reviewer Board: No. 16138.

: Written informed consent was obtained. Registry and the Registration No. of the study/trial: UMIN000034701.

: N/A.

Document is current

Any future updates will be listed below